AXIM Biotechnologies, Inc. (OTCMKTS:AXIM – Get Free Report) saw a large drop in short interest in the month of October. As of October 30th, there was short interest totaling 106,234 shares, a drop of 44.4% from the October 15th total of 191,030 shares. Based on an average trading volume of 225,066 shares, the short-interest ratio is currently 0.5 days.
AXIM Biotechnologies Stock Performance
OTCMKTS:AXIM opened at $0.00 on Monday. AXIM Biotechnologies has a one year low of $0.00 and a one year high of $0.03.
AXIM Biotechnologies Company Profile
AXIM Biotechnologies, Inc. is a biotechnology company focused on developing diagnostic technologies and products. Its activities have included the research and development of rapid, point-of-care tests intended to support the detection and monitoring of medical conditions. The company has historically worked on diagnostic products related to infectious diseases, including COVID-19 testing and antibody detection. AXIM has also explored applications in oral and eye health, including diagnostic approaches designed for use with saliva and other accessible biological samples.
See Also
- Five stocks we like better than AXIM Biotechnologies
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Receive News & Ratings for AXIM Biotechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXIM Biotechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
